UNSPSC 51110000: Antineoplastic agents

This classification denotes substances that inhibit or prevent the proliferation of new abnormal growths of tissue, called neoplasms.

UNSPSC 51110000 Antineoplastic agents is a Family code that encompasses pharmaceutical products procured by state and local health systems, emergency services, and forensic laboratories—including cancer treatments, emergency medications (naloxone), and laboratory-grade drug reference standards used in clinical and forensic analysis. Recent state and local opportunities under this code span naloxone and opioid-response supplies (Seminole County, Florida; City of Tucson Fire Department), emergency medical pharmaceuticals and supplies for EMS operations (Tucson), certified drug reference materials for forensic toxicology testing (Pinellas County, Florida), and generic multi-source pharmaceuticals distributed through cooperative purchasing (MMCAP, Minnesota). The mix of issuing bodies includes county health departments, municipal fire and EMS agencies, county forensic laboratories, and state cooperative purchasing alliances. Repeat buyers include Seminole County (naloxone procurement) and Pinellas County (forensic drug standards through the Paul Coverdell Forensic Sciences Improvement Act Program).

Recent activity concentrates in Florida and Arizona, with MMCAP cooperative purchasing extending across Minnesota and Oregon. The City of Tucson Fire Department issued RFP 260217 (due June 24, 2026) for BLS/ALS pharmaceuticals, supplies, and VendNovation vending machine software—a $2.65 million+ scope with 251 line items, federally funded through ARPA, HUD, and FTA, requiring Arizona State Board of Pharmacy licensure and DEA compliance. Seminole County, Florida issued IFB 60459723LAS (due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, with a two-year term plus one-year renewal option. Pinellas County issued ITQ 26-0305-ITQ (due April 23, 2026) for 131 line items of drug reference standards (ISO/IEC 17025:2017 certified, purity ≥97%) supporting forensic toxicology and seized drug analysis, funded through the Paul Coverdell program ($72,126.85 federal allocation). The MMCAP RFP (S1070000015802, due March 26, 2026) establishes multi-award contracts for generic pharmaceuticals and OTC products through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson), requiring cGMP and DSCSA certification with a 3 percent administrative fee structure.